Publications by authors named "C Gourmelon"

Claim this Profile
R
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
Alberto Picca, Mehdi Touat, Lisa Belin, Carole Gourmelon, Vincent Harlay

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between post-operative hPG (circulating progastrin) detectable level and worse prognosis in glioblastoma.
L Doucet, A Cailleteau, L Vaugier, C Gourmelon, M Bureau

ESMO Open· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating everolimus for the treatment of breast cancer.
Camille Moreau-Bachelard, Marie Robert, Carole Gourmelon, Emmanuelle Bourbouloux, Anne Patsouris

Expert Opin Pharmacother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.
Antoine Seyve, Caroline Dehais, Olivier Chinot, Apolline Djelad, Elisabeth Cohen-Moyal, Carole Gourmelon

Neuro Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma.
Loïg Vaugier, Loïc Ah-Thiane, Maud Aumont, Emmanuel Jouglar, Mario Campone, Carole Gourmelon

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis